Fresenius Medical Care announced that its net income attributable to shareholders for the second quarter increased to €187 million ($200 million), up from €140 million in the previous year. Basic earnings per share increased to €0.64 from €0.48 in the previous year. Quarterly earnings per share on outlook base increased by 18% to from the prior year. However, revenue for the second quarter decreased by 1.2% year-over-year to €4.77 billion. Quarterly revenues were down 1.7% at constant currency. Organic revenue growth was up 2.3%, supported by both segments Care Delivery and Care Enablement. Fr…